EMERALD: A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE) (clinicaltrials.gov) - Sep 23, 2026 - P3 | N=864 | Enrolling by invitation | Sponsor: Biogen | Trial completion date: Mar 2030 ➔ May 2032 | Trial primary completion date: Mar 2030 ➔ May 2032
Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|